Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Safety and Efficacy Evaluation of Vatiquinone (EPI-743) in Children With Leigh Syndrome

NCT02352896 is registered in ClinicalTrials.gov with PTC Therapeutics as lead sponsor.

NCT NCT02352896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02352896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Safety and Efficacy Evaluation of Vatiquinone (EPI-743) in Children With Leigh Syndrome
Lead sponsor
PTC Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2014
Completion date
October 30, 2023
Enrollment
30 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

leigh syndrome